Leaves of Schott and Solander show promise in treating dementia. Simple crush powder has strongest effect on tauopathy and other pathologies. Potential dietary source for dementia prevention.
Researchers studied the effects of Acorus tatarinowii oils on microglial inflammation after ischemic stroke. Results showed AT oils reduced cerebral damage, inflammation, and improved gut microbiota balance. Gut microbiota played a crucial role in the protective effects of AT oils.
Researchers combined essential oils from Acorus tatarinowii and Panax ginseng with Albizia julibrissin flower oil to create a new treatment called CSHVO for depression. CSHVO's effects and mechanisms are still unknown.
Crude polysaccharide AT50 from Acorus tatarinowii improves memory and reduces neuroinflammation in Alzheimer's disease mice. Novel heteropolysaccharide ATP50-3 inhibits proinflammatory factors, showing potential for AD treatment.
Researchers evaluated the clinical efficacy and safety of a combination of two Chinese herbal formulas, PT and AT, for the treatment of Alzheimer's disease. The combination showed potential in improving cognition and functioning without increasing adverse events, but the quality of evidence is low.
Researchers investigated the potential of β-asarone, a compound found in a plant called Acorus tatarinowii Schott, to reduce damage in cells deprived of oxygen and improve learning and memory. The study aims to determine if β-asarone can alleviate cerebral ischemic injury in mice with vascular dementia by acting through the cAMP/PKA/CREB pathway.
Scientists analyzed the mitochondrial genome of Acorus tatarinowii, a traditional Chinese medicinal plant, revealing unique genes, complex chromosome structures, codon usage, repetitive sequences, and RNA editing sites. This enriches mitochondrial genome knowledge for Acoraceae and benefits other species as a reference.
Herbal medicines may be useful for treating cognitive impairment in Alzheimer's disease and vascular dementia, by targeting dysfunction in the neurovascular glial unit.
PTAT decoction, a traditional medicine, showed significant antiepileptic and anxiolytic effects in mice through modulation of GABA neurotransmission and reduction of inflammation, suggesting potential as a natural treatment for epilepsy.
Schott is a medicinal plant used in empirical medicine for various diseases. It has many compounds that provide pharmacological effects, especially for brain and nervous system diseases.
Researchers studied the effects of Shi chang pu (SCP-oil) on the neuroinflammation of Alzheimer's disease. SCP-oil is the main active component of Acorus tatarinowii Schott, a herbal used for AD treatment in China. Results showed that SCP-oil reduced neuroinflammation in the brains of AD model rats by inhibiting the activation of microglia. This study suggests that SCP-oil may have potential as a therapeutic agent for AD.
This study evaluated Traditional Chinese Medicine (TCM) for treating epilepsy. The efficacy and safety of TCM were tested. Results showed that TCM was effective and safe in treating epilepsy. This suggests that TCM could be a potential alternative treatment option for epilepsy patients.
Scientists studied the neuroprotective effects of the traditional Chinese medicine formula Mi-Jian-Chang-Pu on ischemic stroke (IS) using pharmacodynamics, pharmacokinetics, and metabolomics. They tested the individual herbs and major active components of the formula on rats with MCAO-induced brain damage. The study found that MJCPF had a synergistic effect, demonstrating small infarct volume and improved neural function. The levels of inflammatory factors were brought closer to normal. The formula also promoted drug absorption greater than other compounds tested. The findings suggest the scientific potential of TMC formulas in treating ischemic stroke.
Researchers investigated the potential of traditional Chinese medicines Schisandra chinensis and Acorus tatarinowii Schott in Alzheimer's disease treatment and found them to have neuroprotective effects. Although the main anti-Alzheimer's compounds and functional mechanisms are unknown, clinical studies have proven their effectiveness. Further research could lead to a better understanding of these traditional medicines and their potential use in treating Alzheimer's disease.
Scientists used network pharmacology, molecular docking, and animal tests to investigate the effects of Polygala tenuifolia and Acorus tatarinowii in treating Alzheimer's disease (AD). By analyzing active ingredients and targets of the traditional Chinese medicines, they identified core targets and pathways involved in AD. Mice with cognitive impairment were given the treatments, which improved learning and memory abilities and reduced neuron damage. The results suggest that P. tenuifolia and A. tatarinowii have potential for treating AD through multiple components, targets, and pathways.
A. tatarinowii Schott, a traditional Chinese medicine, has been used for centuries to treat neuropsychiatric and digestive disorders. Several studies have shown that it has antidepressant effects, but the mechanisms by which it works are still unknown.
In a study, researchers investigated the effects of Acorus tatarinowii Schott, an herb used in traditional Chinese medicine, on treadmill running endurance in rats. They also looked at the levels of certain neurotransmitters and proteins in the rats' brains. The results showed that the rats who were given the herb had greater endurance and increased levels of serotonin, a neurotransmitter that can affect mood and behavior. The researchers suggest that Acorus tatarinowii Schott may have potential as an anti-fatigue supplement, but more research is needed to fully understand its effects on the central nervous system.